Research On Inventory Management Of NY Blood Products Enterprises

With the rapid economic and social development in China,medical treatment conditions and social security system are gradually improved,and Chinese citizens have a growing demand for high-end medical drugs such as blood products.Especially as the novel coronavirus has swept the country,blood products have played a significant role in disease prevention and treatment in China.In recent years,with the merger and reorganization of blood products companies,the industry concentration increases,and the market competition becomes increasingly fierce.So,only through the brand innovation in enterprise development,such as strengthening management way can increase the strength of market competition occupy a corner,and improve inventory management as an important way to improve enterprise management,enterprise’s inventory turnover and cash flow velocity can improve not only,more conducive to reveal the problems existing in the process of enterprise development.According to the special of blood products industry and the characteristics of blood products,it is necessary to establish an appropriate inventory management mode,optimize the inventory management system,reduce inventory costs and create benefits for enterprises.According to the reality and application of inventory management,this thesis first takes NY Biopharmaceutical Co.Ltd.as an example to conduct in-depth research on its inventory management.This thesis first summarizes the relevant literature at home and abroad;Secondly,it introduces the related theories of inventory management and related inventory products,laying the necessary theoretical basis for further research of this thesis.Again,through to the NY biopharmaceutical company data and information on stock,from purchase,acceptance,storage,outbound,return,etc.,analyzes the basic situation of the company’s inventory management work,and deeply analyzes the company inventory management process related problems and reasons,such as purchasing staff appraisal mechanism lacks,the excessive concentration of suppliers,purchase system is not sound;The acceptance link standard is not strict,the process is not rigorous;The inventory classification method of storage link and the storage cold chain management system are not perfect,the review work of the delivery link is not in place and the supervision of the third party logistics is weak;Return link return process is not reasonable,in-depth analysis of the reasons found that the main reasons are the staff inventory management is not strong,internal control is not sound,the lack of professional talent management,and inventory information management system is not perfect.Therefore,in the improvement process,according to the above problems,the company’s inventory production,acceptance,storage,shipment,return and other five aspects to improve and optimize.Finally,in order to ensure the smooth implementation of the inventory management improvement program,put forward the guarantee measures before,during and after the implementation of the improvement program.This study is expected to be of some significance to improve the inventory management of NY Biopharmaceutical Co.Ltd.,as well as a reference for other blood products enterprises.